Cargando…
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
Autores principales: | Gubatan, John, Levitte, Steven, Balabanis, Tatiana, Patel, Akshar, Sharma, Arpita, Habtezion, Aida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204754/ https://www.ncbi.nlm.nih.gov/pubmed/32387541 http://dx.doi.org/10.1053/j.gastro.2020.05.009 |
Ejemplares similares
-
Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions
por: Gubatan, John, et al.
Publicado: (2021) -
1162: SINGLE-CELL IMMUNE PROFILING AND REPERTOIRE ANALYSIS OF CONVALESCENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND SARS-COV-2 ANTIBODY RESPONSE
por: Gubatan, John Mark, et al.
Publicado: (2022) -
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
por: Weingarden, Alexa R, et al.
Publicado: (2022) -
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
por: Rubin, Samuel J S, et al.
Publicado: (2022) -
Reactive Oxygen Species Imaging in a Mouse Model of Inflammatory Bowel Disease
por: Bronsart, Laura, et al.
Publicado: (2016)